Evidence map›Paper›PMID 41473856›Full record

ArticleAvicenna journal of medicine2025

Chemotherapy and Quality of Life: An Observational Study of Cancer Patients at the Oncology Unit of Tertiary Care Hospital in Islamabad.

Sameen Abbas, Kanza Zahid, Bilal Ashraf, Muhammad Asim Ali, Muhammad Nouman Asghar, Amna Shahid, Kainat Hameed

Abstract read
In one paragraph

Article in Avicenna journal of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sameen AbbasDepartment of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Kanza ZahidDepartment of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
Bilal AshrafDepartment of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.
Muhammad Asim AliFaculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan.
Muhammad Nouman AsgharFaculty of Pharmacy, Gomal University, Dera Ismail Khan, Pakistan.ORCID 0009-0004-8158-5908
Amna ShahidDepartment of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.
Kainat HameedDepartment of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cancer is a global health challenge, with millions of new cases annually. While improving survival rates, the disease and its treatment, particularly chemotherapy, significantly impact patients' quality of life (QoL) and cause side effects that severely affect patients' physical, emotional, and social well-being. As the number of cancer patients is rising in Pakistan, the health care system still faces multiple issues that may have an impact on patient outcomes and QoL. So, this study aims to assess the QoL of cancer patients before and after chemotherapy at a tertiary care hospital in Islamabad. Methodology: A prospective cohort study at PIMS, Islamabad, enrolled 184 chemotherapy patients using consecutive sampling techniques. Ethical approvals and informed consent were obtained. Clinical as well as demographic data, together with well-being (Functional Assessment of Cancer Therapy-General [FACT-G]), were analyzed using SPSS version 21. Results: Of 184 patients, 71.9% had hematological malignancies and 28.1% solid tumors. FACT-G scores demonstrated significant domain-specific improvements following chemotherapy, in which physical and functional well-being improved significantly ( Conclusion: Chemotherapy significantly improved QoL in specific domains, particularly physical and functional well-being, though emotional and social challenges persisted. These findings highlight the need for early detection, comprehensive supportive care, and survivorship programs tailored to the Pakistani context in mitigating these impacts and enhancing patient well-being.

Indexed as

cancerchemotherapyoncologyPakistanquality of life

Identifiers

PMID41473856
PMCPMC12747757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.